CD28 CD19-specific CAR-T cells co-transduced with PD-1 DNR showed the improved function of T cells in vitro and long-lasted T cells in vivo with higher efficacy and better control of tumor cells [158]. This evidence concerns the gene CD19 and neoplasm.